Weighted vest,
does it really help with Attenuation of hip bone loss?
research showsThe grade is D. In 150 adults aged 60-85, 12-month hip trabecular vBMD changed by -1.61 versus -2.52 mg/cm3; adjusted difference +0.91 (97.5% CI -0.27 to 2.09), P=.13.
ads claimGeneral weight-bearing exercise advice does not establish efficacy of this specific vest protocol.
Useful facts when choosing a product
- The trial measured CT and DXA bone density, not fractures.
- Lack of participant blinding was unavoidable and imaging assessors were blinded.
- NIA grants and meal-replacement donation from a Medifast subsidiary were disclosed.
Chamgap Semantic Classification Code
Candidate index · review held
UNK.weighted-vest-worn-about-during-weight-loss.UNK.attenuation-of-hip-bone-loss.reduce.UNKUnknown > weighted vest worn about during weight loss > Unknown > Attenuation of hip bone loss > Reduction claim > Unknown
An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
What the research actually shows
All groups received a 10% weight-loss program. Vest loading replaced lost weight up to 10% of baseline and averaged 7.1 (SD 1.5) h/day. The paper reported model-estimated changes and CIs, not raw SDs of change.
Why this is classified as D (28)
A null objective surrogate endpoint with residual benefit uncertainty gives D with 28 points.
Counterpoint. Fracture prevention remains untested.
Rejudgment record. Cross-check applied — Null 12-month objective hip-density primary endpoint
| Endpoint | S | Surrogate marker - laboratory or imaging measures |
| Replication | R1 | Single confirmatory trial |
| Independence | I1 | Mixed funding sources |
| Effect size | E0 | Null |
| Precision | C0 | The confidence interval leaves room for benefit |
Stored derived and displayed grades match; this is not a current recalculation or validity check (D).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Attenuation of hip bone-density loss | D | Neither CT nor DXA showed a between-group difference. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Beavers KM et al. 2025 INVEST | Three-arm randomized trial | 150 randomized; CT analysis 45/46/47 | NIA grants; in-kind meal replacements from Jason Pharmaceuticals/Medifast | 12-month change in total-hip trabecular vBMD | -1.61 versus -2.52 mg/cm3; difference +0.91 (97.5% CI -0.27 to 2.09) | Pivotal surrogate-endpoint trial |
Receipt — 1 References
All 1 cited sources were verified for existence at the original page (as of 2026-08-07).
Final verification and publication gate: Codex · Evidence date: 2026-08-07 · Corrections: none
Cite this verdict
[Chamgap] Weighted vest x prevention of hip bone loss during weight loss — Evidence Grade D·28. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/joint-bone/weighted-vest-weight-loss-hip-bone-loss/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.